LATEST ALERTS
Italian vape stores prohibited from selling CBD products
26th October 2020 - News analysis |
Italian vape stores will not be able to sell CBD products following the publication of a circular
Regulation and legislation
CBD-Intel regulatory news in brief, 17th-23rd October
23rd October 2020 - Alerts , Regulatory alerts roundup |
This week’s regulatory news in brief includes updates from the Czech Republic, EU, France, Germany, Ireland, Italy, the US, Australia, Colombia, Ecuador, New Zealand and Ukraine
CBD and hemp regulation: confusion in the US
23rd October 2020 - News analysis |
Regulation of CBD at the federal level remains confusingly divided between multiple agencies. Three main bodies have overall control of most aspects of hemp and CBD consumer product regulation
CBD and hemp regulation: the US DEA and its authority
23rd October 2020 - News analysis |
The passage of the 2018 Farm Bill removed hemp and compounds derived from hemp (including CBD) from the CSA. Therefore, the DEA should have very little involvement in enforcing laws and regulations on hemp and CBD
CBD and hemp regulation: the US FDA and its authority
23rd October 2020 - News analysis |
The US Food and Drug Administration (FDA) is a critical agency in the regulatory scheme of CBD products. The 2018 Farm Bill, which legalised hemp and CBD derived from it, granted the FDA the authority to regulate hemp products
CBD and hemp regulation: the USDA and its authority
23rd October 2020 - News analysis |
Among the most important obligations delegated to it in the Farm Bill, the USDA is responsible for rule making regarding production and testing of hemp and approving state and tribal plans for hemp production
What impact could a decision in the recent Dusseldorf lawsuit have on the German CBD sector?
23rd October 2020 - Blogs |
The company of the president of the European Industrial Hemp Association (EIHA) has challenged a ban on the sale of all foods containing CBD
Ministerial decree causes further confusion for the Italian market
22nd October 2020 - News analysis |
A ministerial decree listing oral administration of CBD as a medicine under Italy’s Narcotics Law is meant to clear the way for the introduction of Epidyolex into the market, not to prevent consumer wellness products being sold
Podcast: global CBD markets and their commonalities and differences
22nd October 2020 - Podcasts , Resources |
Our host for today’s podcast is Jon Bruford, a copy editor at CBD-Intel, who will be joined by CBD-Intel market analyst Maria Alejandra Estanga, who analyses the CBD market for European and American countries. In CBD-Intel’s new podcast, Alejandra discusses global CBD markets and their commonalities and differences, analysing each market and its own peculiarities based on regulations, market development » Continue Reading.
Behind the mask: ads regulator refers claims to US Federal Trade Commission
20th October 2020 - News analysis |
The National Advertising Division (NAD) of the US Better Business Bureau has referred advertising claims made by a CBD company to the Federal Trade Commission (FTC)
CBD-Intel regulatory news in brief, 10th-16th October
19th October 2020 - Alerts , Regulatory alerts roundup |
This week’s regulatory news in brief includes updates from the EU, Belgium, France, Germany, Italy Switzerland, the UK, Canada, Mexico, the US, Argentina, Australia, Israel, New Zealand, Nigeria, Rwanda, South Africa and Ukraine
What impact will the US elections have on CBD and cannabis?
16th October 2020 - Blogs |
It’s important to remember that all aspects of cannabis and CBD – even federal decriminalisation or legalisation efforts
Regulatory report: Australia, October 2020
15th October 2020 - Regulatory reports |
CBD is listed on the Controlled Drug Register in Australia, which means it cannot be sold as a consumer product. This report offers an overview of the current regulatory framework in the country for CBD
CBD-Intel regulatory news in brief, 3rd-9th October
9th October 2020 - Alerts , Regulatory alerts roundup |
This week’s regulatory news in brief includes updates from the EU, Austria, France Germany, Italy, the Netherlands, Slovakia, Romania, Spain, the UK, the US, Australia, Colombia, Israel, Lebanon, New Zealand, Russia and Ukraine
Costa Rica looks set to legalise hemp and medical cannabis production
9th October 2020 - News analysis |
A Costa Rican bill legalising the production of hemp and medical cannabis looks likely to pass due to broad support from the ruling coalition and president
Do companies need toxicological study data included in UK Food Standards Agency (FSA) novel food applications for them to be validated?
9th October 2020 - Blogs |
There are still quite a few unanswered questions regarding the novel food application process under the FSA. Fortunately the requirement of having toxicological data
Mushrooms may be good for you – and firms hope that can be good for them too
6th October 2020 - News analysis |
Commercial interest in mushrooms as active ingredients is on the rise – despite legal issues that severely curtail commercial opportunities
Regulatory report: Brazil, October 2020
6th October 2020 - Regulatory reports |
A recent proposal in Brazil could see the legalisation of hemp cultivation for industrial purposes and cannabis for medical use. This report provides an overview of the current regulatory framework
Regulatory report: CBD in food – US state by state
5th October 2020 - Regulatory reports |
This report takes a state-by-state look at the status of CBD in foods in the US, detailing the current framework and status
CBD-Intel regulatory news in brief, 26th September-2nd October
2nd October 2020 - Alerts , Regulatory alerts roundup |
This week’s regulatory news in brief includes updates from Austria, Belgium, Germany, France, Italy, Switzerland, UK, the US, Mexico, Australia, Colombia, Costa Rica, Uruguay and Israel
New regulatory measures for industrial hemp introduced in Zimbabwe
2nd October 2020 - News analysis |
The Zimbabwean agriculture minister has officially published a new statutory instrument to regulate the production, procurement, distribution, possession, sale, provision and transportation of industrial hemp
Is increased uncertainty in established markets driving interest in secondary markets such as Asia?
2nd October 2020 - Blogs |
There has been increased interest in secondary markets that has resulted in some positive developments.
Hopes growing in Brazil for further legalisation of medical cannabis
28th September 2020 - News analysis |
A proposal to be voted on by Brazilian legislators in the coming weeks could legalise the growing of hemp for industrial purposes and cannabis for medical use
CBD-Intel regulatory news in brief, 19th-25th September
25th September 2020 - Alerts , Regulatory alerts roundup |
This week’s regulatory news in brief includes updates from Spain, the UK, the US, Hong Kong, South Africa and Zimbabwe
What impact does the delay in voting on the MORE Act have on the CBD industry?
25th September 2020 - Blogs |
The Marijuana Opportunity Reinvestment and Expungement (MORE) Act was, of course, always more about cannabis than hemp-derived CBD specifically. And, as previously stated, its chances of passing were slim to none.
Why do bills related to cannabinoids keep getting pushed through the US Congress?
21st September 2020 - Blogs |
There does not seem to be much point in continuing to try to force through bills – particularly given that the Republican-controlled senate and presidency opposes any measures and the limited timeframe before the end of the legislative session.
CBD-Intel regulatory news in brief, 12th-18th September
18th September 2020 - Alerts , Regulatory alerts roundup |
This week’s regulatory news in brief includes updates from France, Italy, Poland, Sweden, the US, the British Virgin Islands, Argentina, Australia, Ecuador, Israel, the Philippines and Russia
Regulatory report: Japan, September 2020
17th September 2020 - Regulatory reports |
This regulatory report covers all aspects of the regulatory regime for hemp and CBD in Japan, including medical cannabis and import/export laws
CBD-Intel regulatory news in brief, 5th-11th September
11th September 2020 - Alerts , Regulatory alerts roundup |
This week’s regulatory news in brief includes updates from Czech Republic, France, Germany, Ireland, Lithuania, Malta, Netherlands, Slovakia, Ukraine, the UK, the US, Colombia, Israel and Russia
‘We want MORE’ – US Democrats prepare for House vote on cannabis reform bill
11th September 2020 - News analysis |
The US House of Representatives is expected to hold a historic vote this month on a comprehensive cannabis reform bill that supporters embrace for not only decriminalising marijuana but correcting injustices
Is the argument against classing CBD as a narcotic quite as clear-cut as they say?
11th September 2020 - Blogs |
What should the industry make of the recent paper from 11 industry associations putting forward a unified position on the issues surrounding the potential for CBD to be considered a narcotic? A
CBD industry steps up with funding for ValidCare’s vital liver function study
7th September 2020 - News analysis |
More than a dozen CBD businesses have given their backing to an investigation of the impact of CBD on liver toxicity levels in order to provide regulatory authorities in the US with reliable new data
Multiple proposals could spell legalisation of hemp and CBD in Israel
4th September 2020 - News analysis |
Israel is considering amending the Dangerous Drugs Ordinance, which – if successful – will have a major impact on the market with hemp and CBD products
CBD-Intel regulatory news in brief, 22th August-4th September
4th September 2020 - Alerts , Regulatory alerts roundup |
This week’s regulatory news in brief includes updates from Belgium, Germany, Malta, Canada, the US, Brazil, Chile, Colombia, Indonesia, Israel, New Zealand, Pakistan, Paraguay and Peru
What impact would the US Drug Enforcement Agency (DEA) rules have on the CBD industry if they were enacted in their current form?
4th September 2020 - Blogs |
First it’s important to note that the DEA proposals are only in a draft form and are open to comment until 20th October. They have already received a large number of comments, the majority of which appear to be criticising aspects of the proposed regulatory regime that have raised hackles among the industry.
Licensing difficulties hold back hemp producers in China’s Yunnan province
3rd September 2020 - News analysis |
Companies seeking licences to produce hemp in the Chinese province of Yunnan face a tightening of the application process, according to some who have successfully negotiated the concealed hurdles
Pharma gets bigger with approval for new cannabinoid-based treatments
3rd September 2020 - News analysis |
The pharmaceutical side of the cannabinoid industry continues to grow, with several major announcements expanding treatments and blurring boundaries
Podcast: what can European markets do with CBD Novel Food applications?
2nd September 2020 - Podcasts , Resources |
CBD-Intel managing director, Tim Phillips, discusses the main facts and issues surrounding CBD and Novel Food status in European markets. He presents the key aspects of the delay, the political issues and the impacts released on the European level and the future challenges for the sector.
US DEA raises industry’s hackles with its strict interpretation of 0.3% THC limit
1st September 2020 - News analysis |
Proposed regulations from the US Drug Enforcement Administration (DEA) have riled the hemp and CBD sectors, with opinions divided on what the rule would mean if enacted in its current form
CBD food products to remain illegal for three years
1st September 2020 - Press releases , Resources |
FOR IMMEDIATE RELEASE CBD food products to remain illegal for three years New report from CBD-Intel explores issues surrounding CBD as a novel food Don’t expect to see legal CBD food and drink products before 2023 at the very earliest, a new report from CBD-Intel warns. The use of CBD as a food ingredient has been on hold since European » Continue Reading.
CBD-Intel regulatory news in brief, 22nd-28th August
28th August 2020 - Alerts , Regulatory alerts roundup |
This week’s regulatory news in brief includes updates from the Czech Republic, Sweden, Mexico, the US, Ecuador and Israel
How significant is Charlotte’s Web being denied a trademark?
27th August 2020 - Blogs |
The immediate impact of the decision is a reduction in certainty for CBD firms – not something they need at a time of significantly heightened uncertainty in other areas.
Worse delays feared for European CBD novel food authorisations
27th August 2020 - News analysis |
Do not expect European novel food authorisations before the end of 2022 at the very earliest and do not expect generic authorisations to cover non-applicant products, a new report from CBD-Intel warns
Charlotte’s Web denied US trademark on appeal ‘because CBD oil isn’t legal’
26th August 2020 - News analysis |
Charlotte’s Web has been denied a US trademark on appeal – a ruling that has serious implications for any company in the CBD sector selling food, drink or dietary supplement products in the US
German firm waits to hear whether new CBD oil will be deemed ‘novel food’
24th August 2020 - News analysis |
A German company is still waiting to hear from the authorities two months after launching new CBD products that could be considered food supplements
CBD-Intel regulatory news in brief, 15th-21st August
21st August 2020 - Alerts , Regulatory alerts roundup |
This week’s regulatory news in brief brings updates from France, Germany, Poland, the UK, Canada, Mexico, the US, Argentina, Brazil, Israel, New Zealand, South Africa and Uruguay
What can be made of Canopy’s increased interest in functional ingredients?
21st August 2020 - Blogs |
Canopy, the Canadian cannabinoid company, has continued to commit heavily to BioSteel, a sports nutrition company in which Canopy now owns the majority share.
Italian tobacconists lobby for a monopoly on the sale of CBD flowers
20th August 2020 - News analysis |
A group of tobacco retailers have written to the Italian Tobacconists Federation (FIT) asking it to push for a state monopoly on the sale of CBD flowers
Switzerland edges towards legal cannabis with trials likely next year
17th August 2020 - News analysis |
Switzerland plans to launch trials next year as part of a move toward legalising cannabis with high levels of THC – but it could be several years before Swiss users can legally light up a joint
CBD-Intel regulatory news in brief, 8th-14th August
14th August 2020 - Alerts , Regulatory alerts roundup |
This week’s regulatory news in brief brings updates from Czech Republic, Cyprus, France, Germany, Italy, Switzerland, Canada, Mexico, the US, Israel, Panama, Paraguay, South Africa and Uruguay
